Host: HEK293 cells • AA: 28-306 • Tag: C-terminal His • MW: 32.7 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PPT1 (human, recombinant)

Item No. 38066

Technical Information
Synonyms
  • Palmitoyl-protein Hydrolase 1
  • Palmitoyl-protein Thioesterase 1
  • CLN1
Purity
≥90% estimated by SDS-PAGE
Endotoxin Testing
<1.0 EU/µg determined by the LAL endotoxin assay
Source
Recombinant human C-terminal His-tagged PPT1 expressed in HEK293 cells
Amino Acids
28-306
MW
32.7 kDa
Lyophilized from sterile PBS, pH 7.4
UniProt Accession №
P50897-1
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Palmitoyl-protein thioesterase 1 (PPT1) is a lysosomal hydrolase involved in removing palmitic acid (Item No. 10006627) from post-translationally modified proteins prior to their degradation.1 It is mainly expressed in the brain but is also found in visceral macrophages from liver, lung, and bowel tissues.2 PPT1 depalmitoylates proteins in cells undergoing autophagy, and PPT1 activity is important for axon outgrowth, neurite extension, and dendritic spine morphology.1 Knockout of PPT1 decreases tumor growth in a mouse xenograft model, and high expression of PPT1 is associated with poor overall survival in several cancers.3 Mutations in PPT1 cause infantile neuronal ceroid lipofuscinoses (INCL), an encephalopathy characterized by granular deposits in neurons, vision loss, seizures, mental deterioration, and brain death.4,5 Cayman’s PPT1 (human, recombinant) protein consists of 290 amino acids, has a calculated molecular weight of 32.7 kDa, and a predicted N-terminus of Asp28 after signal peptide cleavage. By SDS-PAGE, under reducing conditions, the apparent molecular mass is 35-41 kDa due to glycosylation.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Koster, K.P., and Yoshii, A. Depalmitoylation by palmitoyl-protein thioesterase 1 in neuronal health and degeneration. Front. Synaptic Neurosci. 11, 25 (2019).

    2. Margraf, L.R., Boriack, R.L., Routheut, A.A., et alTissue expression and subcellular localization of CLN3, the Batten disease protein. Mol. Genet. Metab. 66(4), 283-289 (1999).

    3. Rebecca, V.W., Nicastri, M.C., Fennelly, C., et alPPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discov. 9(2), 220-229 (2019).

    4. Vesa, J., Hellsten, E., Verkruyse, L.A., et alMutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376(6541), 584-587 (1995).

    5. Lu, J.-Y., Verkruyse, L.A., and Hofmann, S.L. Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: Correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase. Proc. Natl. Acad. Sci. USA 93(19), 10046-10050 (1996).